Faculty of Medicine news
By Tod Hoffman, Lady Davis Institute Research reveals that even a tiny mutation can allow the HIV virus to become resistant to therapies using the CRISPR/Cas9 gene-editing platform
McGill University Health Centre RI-MUHC will lead an innovative pan-Canadian network that aims to improve life outcomes for children with brain-based development disabilities RI-MUHC will lead an innovative pan-Canadian network that aims to improve life outcomes for children with brain-based development disabilities
McGill Newsroom McGill, UCLA study of low- and middle-income countries shows paid maternity leave policies could help prevent infant deaths For each additional month of paid maternity leave offered in low- and middle-income countries (LMICs), infant mortality is reduced by 13%, according to a new study by researchers from McGill University and UCLA Fielding School of Public Health.
McGill Newsroom Canadian drug safety network provides reassuring evidence regarding risk of heart failure of anti-diabetes medications Incretin-based drugs, a type of medication used to treat type 2 diabetes, do not increase the risk of being hospitalized for heart failure relative to commonly used combinations of oral anti-diabetic drugs, according to a new study published in the New England Journal of Medicine.
By Julie Robert, McGill University Health Centre Millions of people today take statins to help lower their cholesterol level.
By Maya-Olivia Eyssen, Montreal Neurological Institute and Hospital Montreal high school students to take part in brain quiz.
By Julie Robert, McGill University Health Centre Hip fractures are one of the most common injuries sustained by the elderly population following a fall.
By Chris Chipello, McGill Newsroom Surprisingly complex interactions between neurotransmitter receptors and other key proteins help explain the brain’s ability to process information with lightning speed, according to a new study.
By Tod Hoffman, Lady Davis Institute for Medical Research The use of incretin-based drugs is not associated with an increased risk of pancreatic cancer in patients with type 2 diabetes, according to a study published in the latest issue of the British Medical Journal (BMJ). The research was conducted by the Canadian Network for Observational Drug Effect Studies (CNODES), which used the health records of almost 1 million patients with types 2 diabetes.
By Julie Robert, McGill University Health Centre A research team, led by the Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal, has broken new ground in our understanding of the complex functioning of the brain.
Dr. Keiko Shikako-Thomas, Assistant Professor at SPOT, has been awarded a Canada Research Chair (CRC) in Childhood Disability: Participation and Knowledge Translation. Read more in the McGill Reporter.
SPOT Faculty members Dr. Keiko Shikako-Thomas (PI) and Dr. Stefanie Blain-Moraes (co-PI) awarded a CIHR Planning Grant
SPOT Faculty members Dr. Keiko Shikako-Thomas (PI) and Dr. Stefanie Blain-Moraes (co-PI) have been awarded a CIHR Planning Grant for the project entitled, “Adaptive-Use Music Technology for children with developmental disabilities”.
Dr. Marie-Hélène Boudrias, Assistant Professor at SPOT, awarded funding from the Québec Bio-imaging Network (QBIN) / FRQS
Dr. Marie-Hélène Boudrias, Assistant Professor at SPOT, has been awarded funding from the Québec Bio-imaging Network (QBIN) / FRQS – Pilot Project for her project, “Identification of neural substrates underlying neuroplasticity events induced by acute cardiovascular exercise.” The goal of this project is to explore the role of exercise in motor memory consolidation. Dr. Marc Roig is Co-PI.
Dr. Isabelle Gagnon, Assistant Professor at SPOT, has been awarded a CIHR Team Grant to develop the “Canadian Traumatic Brain Injury (TBI) Research Consortium”. The goal of this new research group is to improve the delivery of health care to Canadians with TBI from coast to coast, and also in a global context, by and with scientists, patients and public health leaders. Dr. Gagnon has also been named Lead on the Trauma Strategic Group, an integral part of REPAR’s Scientific Council / Conseil scientifique.